-
1
-
-
0030795733
-
Vascular endothelial growth factor: Crystal structure and functional mapping of the kinase domain receptor binding site
-
DOI 10.1073/pnas.94.14.7192
-
Y.A. Muller, B. Li, H.W. Christinger, J.A. Wells, B.C. Cunningham, and A.M. De Vos Vascular endothelial growth factor: crystal structure and functional mapping of the kinase domain receptor binding site Proc. Natl. Acad. Sci. USA 94 1997 7192 7197 (Pubitemid 27345291)
-
(1997)
Proceedings of the National Academy of Sciences of the United States of America
, vol.94
, Issue.14
, pp. 7192-7197
-
-
Muller, Y.A.1
Li, B.2
Christinger, H.W.3
Wells, J.A.4
Cunningham, B.C.5
De Vos, A.M.6
-
2
-
-
33749028188
-
Vascular endothelial growth factor signaling pathways: Therapeutic perspective
-
DOI 10.1158/1078-0432.CCR-06-1520
-
M. Kowanetz, and N. Ferrara Vascular endothelial growth factor signaling pathways: therapeutic perspective Clin. Cancer Res. 12 2006 5018 5022 (Pubitemid 44453326)
-
(2006)
Clinical Cancer Research
, vol.12
, Issue.17
, pp. 5018-5022
-
-
Kowanetz, M.1
Ferrara, N.2
-
3
-
-
0034648765
-
Angiogenesis in cancer and other diseases
-
P. Carmeliet, and R.K. Jain Angiogenesis in cancer and other diseases Nature 407 2000 249 257
-
(2000)
Nature
, vol.407
, pp. 249-257
-
-
Carmeliet, P.1
Jain, R.K.2
-
4
-
-
63949086049
-
Intradermal delivery of plasmid VEGF(165) by electroporation promotes wound healing
-
B. Ferraro, Y.L. Cruz, D. Coppola, and R. Heller Intradermal delivery of plasmid VEGF(165) by electroporation promotes wound healing Mol. Ther. 17 2009 651 657
-
(2009)
Mol. Ther.
, vol.17
, pp. 651-657
-
-
Ferraro, B.1
Cruz, Y.L.2
Coppola, D.3
Heller, R.4
-
5
-
-
27144440343
-
Vascular endothelial growth factor (VEGF) production by the monkey corpus luteum during the menstrual cycle: Isoform-selective messenger RNA expression in vivo and hypoxia-regulated protein secretion in vitro
-
DOI 10.1095/biolreprod.105.039875
-
M. Tesone, R.L. Stouffer, S.M. Borman, J.D. Hennebold, and T.A. Molskness Vascular endothelial growth factor (VEGF) production by the monkey corpus luteum during the menstrual cycle: isoform-selective messenger RNA expression in vivo and hypoxia-regulated protein secretion in vitro Biol. Reprod. 73 2005 927 934 (Pubitemid 41507495)
-
(2005)
Biology of Reproduction
, vol.73
, Issue.5
, pp. 927-934
-
-
Tesone, M.1
Stouffer, R.L.2
Borman, S.M.3
Hennebold, J.D.4
Molskness, T.A.5
-
6
-
-
73249132759
-
An essential role for RPE-derived soluble VEGF in the maintenance of the choriocapillaris
-
M. Saint-Geniez, T. Kurihara, E. Sekiyama, A.E. Maldonado, and P.A. D'Amore An essential role for RPE-derived soluble VEGF in the maintenance of the choriocapillaris Proc. Nat. Acad. Sci. 106 2009 18751 18756
-
(2009)
Proc. Nat. Acad. Sci.
, vol.106
, pp. 18751-18756
-
-
Saint-Geniez, M.1
Kurihara, T.2
Sekiyama, E.3
Maldonado, A.E.4
D'Amore, P.A.5
-
7
-
-
77951621138
-
MicroRNA-mediated integration of haemodynamics and Vegf signalling during angiogenesis
-
S. Nicoli, C. Standley, P. Walker, A. Hurlstone, K.E. Fogarty, and N.D. Lawson MicroRNA-mediated integration of haemodynamics and Vegf signalling during angiogenesis Nature 464 2010 1196 1200
-
(2010)
Nature
, vol.464
, pp. 1196-1200
-
-
Nicoli, S.1
Standley, C.2
Walker, P.3
Hurlstone, A.4
Fogarty, K.E.5
Lawson, N.D.6
-
8
-
-
85047694751
-
Progress on new vaccine strategies for the immunotherapy and prevention of cancer
-
DOI 10.1172/JCI200421926
-
J.A. Berzofsky, M. Terabe, S. Oh, I.M. Belyakov, J.D. Ahlers, J.E. Janik, and J.C. Morris Progress on new vaccine strategies for the immunotherapy and prevention of cancer J. Clin. Invest. 113 2004 1515 1525 (Pubitemid 39071672)
-
(2004)
Journal of Clinical Investigation
, vol.113
, Issue.11
, pp. 1515-1525
-
-
Berzofsky, J.A.1
Terabe, M.2
Oh, S.3
Belyakov, I.M.4
Ahlers, J.D.5
Janik, J.E.6
Morris, J.C.7
-
10
-
-
0037968240
-
Gene transfer as a tool to induce therapeutic vascular growth
-
DOI 10.1038/nm0603-694
-
S. Yla-Herttuala, and K. Alitalo Gene transfer as a tool to induce therapeutic vascular growth Nat. Med. 9 2003 694 701 (Pubitemid 36749218)
-
(2003)
Nature Medicine
, vol.9
, Issue.6
, pp. 694-701
-
-
Yla-Herttuala, S.1
Alitalo, K.2
-
11
-
-
70350002279
-
Adverse effects of anticancer agents that target the VEGF pathway
-
H.X. Chen, and J.N. Cleck Adverse effects of anticancer agents that target the VEGF pathway Nat. Rev. Clin. Oncol. 6 2009 465 477
-
(2009)
Nat. Rev. Clin. Oncol.
, vol.6
, pp. 465-477
-
-
Chen, H.X.1
Cleck, J.N.2
-
12
-
-
0024818355
-
Vascular endothelial growth factor is a secreted angiogenic mitogen
-
D.W. Leung, G. Cachianes, W.J. Kuang, D.V. Goeddel, and N. Ferrara Vascular endothelial growth factor is a secreted angiogenic mitogen Science 246 1989 1306 1309 (Pubitemid 20066716)
-
(1989)
Science
, vol.246
, Issue.4935
, pp. 1306-1309
-
-
Leung, D.W.1
Cachianes, G.2
Kuang, W.-J.3
Goeddel, D.V.4
Ferrara, N.5
-
13
-
-
0024801035
-
Vascular permeability factor, an endothelial cell mitogen related to PDGF
-
P.J. Keck, S.D. Hauser, G. Krivi, K. Sanzo, T. Warren, J. Feder, and D.T. Connolly Vascular permeability factor, an endothelial cell mitogen related to PDGF Science 246 1989 1309 1312 (Pubitemid 20066717)
-
(1989)
Science
, vol.246
, Issue.4935
, pp. 1309-1312
-
-
Keck, P.J.1
Hauser, S.D.2
Krivi, G.3
Sanzo, K.4
Warren, T.5
Feder, J.6
Connolly, D.T.7
-
14
-
-
77649096200
-
Binding to the extracellular matrix and proteolytic processing: Two key mechanisms regulating vascular endothelial growth factor action
-
N. Ferrara Binding to the extracellular matrix and proteolytic processing: two key mechanisms regulating vascular endothelial growth factor action Mol. Biol. Cell 21 2010 687 690
-
(2010)
Mol. Biol. Cell
, vol.21
, pp. 687-690
-
-
Ferrara, N.1
-
15
-
-
0033781533
-
Purification and refolding of vascular endothelial growth factor-B
-
S.D. Scrofani, L.J. Fabri, P. Xu, P. Maccarone, and A.D. Nash Purification and refolding of vascular endothelial growth factor-B Protein Sci. 9 2000 2018 2025
-
(2000)
Protein Sci.
, vol.9
, pp. 2018-2025
-
-
Scrofani, S.D.1
Fabri, L.J.2
Xu, P.3
MacCarone, P.4
Nash, A.D.5
-
16
-
-
0029937679
-
The carboxyl-terminal domain (111-165) of vascular endothelial growth factor is critical for its mitogenic potency
-
DOI 10.1074/jbc.271.13.7788
-
B.A. Keyt, L.T. Berleau, H.V. Nguyen, H. Chen, H. Heinsohn, R. Vandlen, and N. Ferrara The carboxyl-terminal domain(111165) of vascular endothelial growth factor is critical for its mitogenic potency J. Biol. Chem. 271 1996 7788 7795 (Pubitemid 26111064)
-
(1996)
Journal of Biological Chemistry
, vol.271
, Issue.13
, pp. 7788-7795
-
-
Keyt, B.A.1
Berleau, L.T.2
Nguyen, H.V.3
Chen, H.4
Heinsohn, H.5
Vandlen, R.6
Ferrara, N.7
|